Tower Research Capital LLC (TRC)
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1533421
NEW YORK, NY
Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,653
-$41,719 QoQ
Shares Held
1,134
-96.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $67,724,931 across 440 Biotechnology names. ZNTL ranks #369 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
12,112 | $8,844,787 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,904 | $6,208,692 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,378 | $3,382,617 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,627 | $3,185,285 | |
| 5 | INSM |
INSMED Inc
|
15,410 | $2,519,843 | |
| 6 | LKFT |
Lakefront Biotherapeutics NV
|
66,536 | $1,996,080 | |
| 7 | MRNA |
Moderna, Inc.
|
33,728 | $1,713,382 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
14,349 | $1,065,556 |
All Filings in ZNTL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,653 | 1,134 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $44,372 | 29,386 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $19,852 | 17,114 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,333 | 5,241 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $26,164 | 8,635 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $29,252 | 7,949 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $153,313 | 37,485 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $1,008 | 64 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $54,766 | 3,615 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $20,581 | 1,026 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $195,212 | 6,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $35,965 | 2,091 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $51,920 | 2,578 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $130,414 | 6,021 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $214,684 | 7,640 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,900 | 518 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $331,364 | 3,942 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $174,396 | 2,617 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $164,068 | 3,084 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $62,655 | 1,444 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $37,292 | 718 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $301,859 | 9,234 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $24,490 | 510 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||